CoChat

MDMA (“Ecstasy”) and panic disorder: Induction by a single dose

Open access
McCann, Una D., Ricaurte, George A. · 1992 · Biological Psychiatry
Cited by 81

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

( +_ )3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic amphetamine analogue used recreationally by humans in the United States (Pcroutka 1987) and Western Europe (Anon 1992), and is thought by some to have potential utility as a psychotherapoutic adjunct (Grinspoon and Bakalar 1986). It is generally believed that MDMA acts via central monoamines, primariJy by inducing transmitter release and interfering with monoamine reuptake inactivation (Johnson et al 1991; McKenna and Peroutka 1990). In animals, MDMA has been shown to damage brain serotonin neurons, and in the monkey the neurotoxic dose closely approximates the dose typically ingested by humans (Ricaurte et al 1988). Concern that MDMA may damage serotonin neurons in the human brain is largely responsible for MDMA's Schedule I status in the United States, and consequently, the dearth of controlled studies comparing the risks of MDMA to its possible benefit as a therapeutic adjunct. There have been several recent reports of lasting adverse neuropsychiatric sequelae in humans who have taken repeated (usually high) doses of MDMA (Crcighton et al 1991; Benazzi and Mazzoli 1991; McGuir¢ and Fahy 1991; Schifano 1991; McCann and Ricaurte 1991). These reports suggest that individuals with prior psychiatric histories may have an increased susceptibility to MDMA's adverse effects. Lingering psychiatric syndromes associated with MDMA ingestion have included chronic paranoid psychosis (Schifano 1991; McGuir¢ and Fahy 1991), recurrent acute paranoid psychosis (Crcighton et al 1991), depression with suicidality (Benazzi and Mazzoli 1991), and panic disorder with secondary depression (McCann and Ricaurte 1991). Although untoward effects of high neurotoxic doses of MDMA might be anticipated, particularly in vulnerable individuals, enduring psychiatric illness following a single moderate dose of MDMA in a healthy individual has not been reported. We describe an individual with no prior psychiatric history who developed panic disorder after ingesting a single typical dose of MDMA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0006-3223(92)90185-3

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 81

Metadata

Authors
McCann, U. D., & Ricaurte, G. A.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
1992-11
Volume
32
Issue
10
Pages
950-953
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2040452225
Cited by
81
References
2
FWCI
3.49
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MDMA (“Ecstasy”) and panic disorder: Induction by a single dose. https://app.cochat.ai/papers/10.1016/0006-3223(92)90185-3
The paper
McCann, U. D., & Ricaurte, G. A. (1992). MDMA (“Ecstasy”) and panic disorder: Induction by a single dose. Biological Psychiatry. https://doi.org/10.1016/0006-3223(92)90185-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.